Cargando…

Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1)

OBJECTIVES: The objectives of this study were to estimate the direct and indirect excess costs of type 2 diabetes mellitus (T2D) using data representative for the German adult population and to investigate the association of sociodemographic and clinical determinants with these excess costs. SETTING...

Descripción completa

Detalles Bibliográficos
Autores principales: König, Hannah, Rommel, A, Baumert, Jens, Schmidt, Christian, König, Hans-Helmut, Brettschneider, Christian, Konnopka, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061816/
https://www.ncbi.nlm.nih.gov/pubmed/33883150
http://dx.doi.org/10.1136/bmjopen-2020-043944
_version_ 1783681639974436864
author König, Hannah
Rommel, A
Baumert, Jens
Schmidt, Christian
König, Hans-Helmut
Brettschneider, Christian
Konnopka, Alexander
author_facet König, Hannah
Rommel, A
Baumert, Jens
Schmidt, Christian
König, Hans-Helmut
Brettschneider, Christian
Konnopka, Alexander
author_sort König, Hannah
collection PubMed
description OBJECTIVES: The objectives of this study were to estimate the direct and indirect excess costs of type 2 diabetes mellitus (T2D) using data representative for the German adult population and to investigate the association of sociodemographic and clinical determinants with these excess costs. SETTING: We calculated mean annual costs for individuals with T2D and a control group without diabetes, using data on healthcare utilisation and productivity losses from the cross-sectional German Health Interview and Examination Survey for Adults. We adjusted for group differences using entropy balancing and estimated excess costs for total, direct, indirect costs and additional cost categories using generalised linear models. We performed subgroup analyses to investigate the association of sociodemographic (age, sex and education) and clinical determinants (diabetes duration, glycaemic index and complications) with excess costs. PARTICIPANTS: The final study sample included n=325 individuals with T2D and n=4490 individuals without diabetes in the age between 18 and 79 years. RESULTS: Total excess costs amounted to €927, of which €719 were attributable to direct and €209 to indirect excess costs. Total costs were significantly increased by 28% for T2D compared with controls. Group differences in direct, outpatient and medication costs were statistically significant. Medication costs were 88% higher for T2D and had the highest share in direct excess costs. With respect to specific determinants, direct excess costs ranged from €203 for 4–10 years diabetes duration to €1405 for diabetes complications. Indirect excess costs ranged from €−544 for >10 years diabetes duration to €995 for high education. CONCLUSIONS: T2D was associated with high costs, mainly due to direct costs. As pointed out by our results, diabetes complications and comorbidities have a large impact on the costs, leaving medication costs as main contributor of T2D excess costs.
format Online
Article
Text
id pubmed-8061816
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-80618162021-05-11 Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1) König, Hannah Rommel, A Baumert, Jens Schmidt, Christian König, Hans-Helmut Brettschneider, Christian Konnopka, Alexander BMJ Open Diabetes and Endocrinology OBJECTIVES: The objectives of this study were to estimate the direct and indirect excess costs of type 2 diabetes mellitus (T2D) using data representative for the German adult population and to investigate the association of sociodemographic and clinical determinants with these excess costs. SETTING: We calculated mean annual costs for individuals with T2D and a control group without diabetes, using data on healthcare utilisation and productivity losses from the cross-sectional German Health Interview and Examination Survey for Adults. We adjusted for group differences using entropy balancing and estimated excess costs for total, direct, indirect costs and additional cost categories using generalised linear models. We performed subgroup analyses to investigate the association of sociodemographic (age, sex and education) and clinical determinants (diabetes duration, glycaemic index and complications) with excess costs. PARTICIPANTS: The final study sample included n=325 individuals with T2D and n=4490 individuals without diabetes in the age between 18 and 79 years. RESULTS: Total excess costs amounted to €927, of which €719 were attributable to direct and €209 to indirect excess costs. Total costs were significantly increased by 28% for T2D compared with controls. Group differences in direct, outpatient and medication costs were statistically significant. Medication costs were 88% higher for T2D and had the highest share in direct excess costs. With respect to specific determinants, direct excess costs ranged from €203 for 4–10 years diabetes duration to €1405 for diabetes complications. Indirect excess costs ranged from €−544 for >10 years diabetes duration to €995 for high education. CONCLUSIONS: T2D was associated with high costs, mainly due to direct costs. As pointed out by our results, diabetes complications and comorbidities have a large impact on the costs, leaving medication costs as main contributor of T2D excess costs. BMJ Publishing Group 2021-04-21 /pmc/articles/PMC8061816/ /pubmed/33883150 http://dx.doi.org/10.1136/bmjopen-2020-043944 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Diabetes and Endocrinology
König, Hannah
Rommel, A
Baumert, Jens
Schmidt, Christian
König, Hans-Helmut
Brettschneider, Christian
Konnopka, Alexander
Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1)
title Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1)
title_full Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1)
title_fullStr Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1)
title_full_unstemmed Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1)
title_short Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1)
title_sort excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the german health interview and examination survey for adults (degs1)
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061816/
https://www.ncbi.nlm.nih.gov/pubmed/33883150
http://dx.doi.org/10.1136/bmjopen-2020-043944
work_keys_str_mv AT konighannah excesscostsoftype2diabetesandtheirsociodemographicandclinicaldeterminantsacrosssectionalstudyusingdatafromthegermanhealthinterviewandexaminationsurveyforadultsdegs1
AT rommela excesscostsoftype2diabetesandtheirsociodemographicandclinicaldeterminantsacrosssectionalstudyusingdatafromthegermanhealthinterviewandexaminationsurveyforadultsdegs1
AT baumertjens excesscostsoftype2diabetesandtheirsociodemographicandclinicaldeterminantsacrosssectionalstudyusingdatafromthegermanhealthinterviewandexaminationsurveyforadultsdegs1
AT schmidtchristian excesscostsoftype2diabetesandtheirsociodemographicandclinicaldeterminantsacrosssectionalstudyusingdatafromthegermanhealthinterviewandexaminationsurveyforadultsdegs1
AT konighanshelmut excesscostsoftype2diabetesandtheirsociodemographicandclinicaldeterminantsacrosssectionalstudyusingdatafromthegermanhealthinterviewandexaminationsurveyforadultsdegs1
AT brettschneiderchristian excesscostsoftype2diabetesandtheirsociodemographicandclinicaldeterminantsacrosssectionalstudyusingdatafromthegermanhealthinterviewandexaminationsurveyforadultsdegs1
AT konnopkaalexander excesscostsoftype2diabetesandtheirsociodemographicandclinicaldeterminantsacrosssectionalstudyusingdatafromthegermanhealthinterviewandexaminationsurveyforadultsdegs1